SPAGO — Spago Nanomedical AB (publ) Cashflow Statement
0.000.00%
- SEK91.30m
- SEK61.63m
- SEK0.44m
Annual cashflow statement for Spago Nanomedical AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -39.2 | -39.5 | -43.1 | -33.7 | — |
| Depreciation | |||||
| Non-Cash Items | 0.376 | 0.356 | 0.472 | 0.294 | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.25 | 0.922 | -2.31 | -1.56 | -28.3 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -35.6 | -38.2 | -44.9 | -34.7 | -28.3 |
| Capital Expenditures | — | — | -0.153 | -0.23 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -4.63 | -3.83 | -0.353 | — | 0.633 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.63 | -3.83 | -0.506 | -0.23 | 0.633 |
| Financing Cash Flow Items | 64.2 | 51.7 | 28.5 | — | 24.9 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 64.2 | 51.7 | 28.5 | 22.2 | 24.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 24 | 9.64 | -16.9 | -12.7 | -2.8 |